413 related articles for article (PubMed ID: 28640249)
21. MYBL2 haploinsufficiency increases susceptibility to age-related haematopoietic neoplasia.
Clarke M; Dumon S; Ward C; Jäger R; Freeman S; Dawood B; Sheriff L; Lorvellec M; Kralovics R; Frampton J; García P
Leukemia; 2013 Mar; 27(3):661-70. PubMed ID: 22910183
[TBL] [Abstract][Full Text] [Related]
22. C-terminal truncated hepatitis B virus X protein promotes hepatocellular carcinogenesis through induction of cancer and stem cell-like properties.
Ng KY; Chai S; Tong M; Guan XY; Lin CH; Ching YP; Xie D; Cheng AS; Ma S
Oncotarget; 2016 Apr; 7(17):24005-17. PubMed ID: 27006468
[TBL] [Abstract][Full Text] [Related]
23. B-Myb prevents growth arrest associated with terminal differentiation of monocytic cells.
Bies J; Hoffman B; Amanullah A; Giese T; Wolff L
Oncogene; 1996 Jan; 12(2):355-63. PubMed ID: 8570212
[TBL] [Abstract][Full Text] [Related]
24. Regulation of the cell cycle by B-Myb.
Bessa M; Joaquin M; Tavner F; Saville MK; Watson RJ
Blood Cells Mol Dis; 2001; 27(2):416-21. PubMed ID: 11259164
[TBL] [Abstract][Full Text] [Related]
25. RelB/NF-κB links cell cycle transition and apoptosis to endometrioid adenocarcinoma tumorigenesis.
Ge QL; Liu SH; Ai ZH; Tao MF; Ma L; Wen SY; Dai M; Liu F; Liu HS; Jiang RZ; Xue ZW; Jiang YH; Sun XH; Hu YM; Zhao YX; Chen X; Tao Y; Zhu XL; Ding WJ; Yang BQ; Liu DD; Zhang XR; Teng YC
Cell Death Dis; 2016 Oct; 7(10):e2402. PubMed ID: 27711077
[TBL] [Abstract][Full Text] [Related]
26. Transcriptional activation potential of normal and tumor-associated myb isoforms does not correlate with their ability to block GCSF-induced terminal differentiation of murine myeloid precursor cells.
Patel G; Tantravahi R; Oh IH; Reddy EP
Oncogene; 1996 Sep; 13(6):1197-208. PubMed ID: 8808694
[TBL] [Abstract][Full Text] [Related]
27. Redundant functions of B-Myb and c-Myb in differentiating myeloid cells.
Golay J; Broccoli V; Borleri GM; Erba E; Faretta M; Basilico L; Ying GG; Piccinini G; Shapiro LH; Lovrić J; Nawrath M; Mölling K; Rambaldi A; Introna M
Cell Growth Differ; 1997 Dec; 8(12):1305-16. PubMed ID: 9419419
[TBL] [Abstract][Full Text] [Related]
28. Relation of immune semaphorin/plexin signaling to carcinogenesis.
Műzes G; Sipos F
Eur J Cancer Prev; 2014 Sep; 23(5):469-76. PubMed ID: 24922268
[TBL] [Abstract][Full Text] [Related]
29. Characterizing and Targeting Genes Regulated by Transcription Factor MYBL2 in Lung Adenocarcinoma Cells.
Lee Y; Wu Z; Yang S; Schreiner SM; Gonzalez-Smith LD; Rhie SK
Cancers (Basel); 2022 Oct; 14(20):. PubMed ID: 36291764
[TBL] [Abstract][Full Text] [Related]
30. Expression and characterization of c-Myb in prenatal odontogenesis.
Matalová E; Buchtová M; Tucker AS; Bender TP; Janečková E; Lungová V; Balková S; Smarda J
Dev Growth Differ; 2011 Aug; 53(6):793-803. PubMed ID: 21762405
[TBL] [Abstract][Full Text] [Related]
31. Human T-cell lymphotropic virus type 1 Tax represses c-Myb-dependent transcription through activation of the NF-kappaB pathway and modulation of coactivator usage.
Nicot C; Mahieux R; Pise-Masison C; Brady J; Gessain A; Yamaoka S; Franchini G
Mol Cell Biol; 2001 Nov; 21(21):7391-402. PubMed ID: 11585920
[TBL] [Abstract][Full Text] [Related]
32. Pleiotropic effects of methionine adenosyltransferases deregulation as determinants of liver cancer progression and prognosis.
Frau M; Feo F; Pascale RM
J Hepatol; 2013 Oct; 59(4):830-41. PubMed ID: 23665184
[TBL] [Abstract][Full Text] [Related]
33. The A-Myb transcription factor is a marker of centroblasts in vivo.
Golay J; Broccoli V; Lamorte G; Bifulco C; Parravicini C; Pizzey A; Thomas NS; Delia D; Ferrauti P; Vitolo D; Introna M
J Immunol; 1998 Mar; 160(6):2786-93. PubMed ID: 9510180
[TBL] [Abstract][Full Text] [Related]
34. Mouse Incisor Stem Cell Niche and Myb Transcription Factors.
Svandova E; Vesela B; Smarda J; Hampl A; Radlanski RJ; Matalova E
Anat Histol Embryol; 2015 Oct; 44(5):338-44. PubMed ID: 25182175
[TBL] [Abstract][Full Text] [Related]
35. Distal regulation of c-myb expression during IL-6-induced differentiation in murine myeloid progenitor M1 cells.
Zhang J; Han B; Li X; Bies J; Jiang P; Koller RP; Wolff L
Cell Death Dis; 2016 Sep; 7(9):e2364. PubMed ID: 27607579
[TBL] [Abstract][Full Text] [Related]
36. PARP co-activates B-MYB through enhanced phosphorylation at cyclin/cdk2 sites.
Santilli G; Cervellera MN; Johnson TK; Lewis RE; Iacobelli S; Sala A
Oncogene; 2001 Dec; 20(57):8167-74. PubMed ID: 11781832
[TBL] [Abstract][Full Text] [Related]
37. Defective Myb Function Ablates Cyclin E1 Expression and Perturbs Intestinal Carcinogenesis.
Cheasley D; Pereira L; Sampurno S; Sieber O; Jorissen R; Xu H; Germann M; Yuqian Y; Ramsay RG; Malaterre J
Mol Cancer Res; 2015 Aug; 13(8):1185-96. PubMed ID: 25934694
[TBL] [Abstract][Full Text] [Related]
38. Mybl2 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q 13.1.
Noben-Trauth K; Copeland NG; Gilbert DJ; Jenkins NA; Sonoda G; Testa JR; Klempnauer KH
Genomics; 1996 Aug; 35(3):610-2. PubMed ID: 8812502
[TBL] [Abstract][Full Text] [Related]
39. c-Myb and p300 regulate hematopoietic stem cell proliferation and differentiation.
Sandberg ML; Sutton SE; Pletcher MT; Wiltshire T; Tarantino LM; Hogenesch JB; Cooke MP
Dev Cell; 2005 Feb; 8(2):153-66. PubMed ID: 15691758
[TBL] [Abstract][Full Text] [Related]
40. Resistance to apoptosis in CTLL-2 cells overexpressing B-Myb is associated with B-Myb-dependent bcl-2 induction.
Grassilli E; Salomoni P; Perrotti D; Franceschi C; Calabretta B
Cancer Res; 1999 May; 59(10):2451-6. PubMed ID: 10344757
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
